Skip to main content

Table 5 Predictive factors for disease free survival

From: A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases

 

DFS

 

Patients

HR : (95% CI)

(p)

Gender: Female

1.17: (0.74 – 1.86)

0.51

Age at SBRT 65+

0.72: (0.46 – 1.15)

0.17

Adenocarcinoma Histology:

1.28 : (0.75 – 2.19)

0.36

Lesions : pulmonary

0.47 : (0.23 – 0.95)

0.02

Number of lesions : 3+

1.17 : (0.70 – 1.98)

0.55

Number of hepatic lesions : 3+

1.40 : (0.79 – 2.48)

0.25

Timing of Metastases: < one year

0.67: (0.37 - 1.22)

0.19

    More than 1 year

1.04: (0.60 – 1.79)

0.90

Prior chemotherapy

4.51: (1.10 – 18.47)

0.007

3+ chemotherapies before SBRT :

1.20: (0.63 – 2.25)

0.59

Prior PD with previous CT

1.31: (0.74 – 2.32)

0.37